Search results for "Vaccines"
CDC publishes recommendations on use of RSV vaccines
The two vaccines for respiratory syncytial virus (RSV) were approved by the FDA for older adults in May.
https://acpinternist.org/weekly/archives/2023/08/01/4.htm
1 Aug 2023
RSV vaccines new tool for physicians
The CDC's Advisory Committee on Immunization Practices recommended in June that adults ages 60 years and older may receive a single dose of an RSV vaccine, using shared clinical decision making.
https://acpinternist.org/archives/2023/10/rsv-vaccines-new-tool-for-physicians.htm
1 Oct 2023
New findings on antiviral flu treatment
A recent study raises doubts about whether oseltamivir should be promoted as a way to prevent hospitalization in low-risk patients.
https://acpinternist.org/archives/2023/11/new-findings-on-antiviral-flu-treatment.htm
1 Nov 2023
Coadministration of zoster vaccine, COVID-19 booster appears safe, effective
An industry trial found that coadministration of an mRNA COVID-19 booster vaccine with a first dose of recombinant zoster vaccine was immunologically noninferior to spacing the shots two weeks apart, with a similar safety and reactogenicity profile.
https://acpinternist.org/weekly/archives/2023/06/27/2.htm
27 Jun 2023
Interim data find vaccine 66% to 85% effective against symptomatic RSV in older adults
The results from a large ongoing phase 3 trial show success in protection from respiratory syncytial virus (RSV)-associated lower respiratory tract illness on two important primary endpoints, although reductions in hospitalization and death have yet to be shown.
https://acpinternist.org/weekly/archives/2023/04/11/1.htm
11 Apr 2023
New vaccines are on the scene
This month's issue addresses new vaccines, screening for anxiety, and detecting and treating loneliness.
https://acpinternist.org/archives/2023/10/new-vaccines-are-on-the-scene.htm
1 Oct 2023
New COVID-19 vaccines tested, authorization changes in progress for existing vaccines
The FDA further limited use of the Johnson & Johnson (Janssen) vaccine and scheduled advisory committee meetings on other vaccine questions. Two non-mRNA vaccines showed effectiveness, and other studies looked at antibody prevalence, home test accuracy, and long-term symptoms.
https://acpinternist.org/weekly/archives/2022/05/10/2.htm
10 May 2022
RSV vaccine approved; several actions on opioids
This column reviews recent recalls, alerts, and approvals.
https://acpinternist.org/archives/2023/06/rsv-vaccine-approved-several-actions-on-opioids.htm
1 Jun 2023
Latest ACIP immunization schedule updates guidance on COVID-19, pneumococcal vaccines
The annual immunization schedule consolidates and summarizes updates to the recommendations of the Advisory Committee on Immunization Practices (ACIP).
https://acpinternist.org/weekly/archives/2023/02/14/1.htm
14 Feb 2023
CDC and FDA weigh in on safety of bivalent vaccine; research examines COVID-19 sequelae, omicron variants
The CDC and FDA said an observed association of ischemic stroke with the Pfizer-BioNTech bivalent booster is very unlikely to represent a true clinical risk. New studies reported on symptoms a year after mild COVID-19 and estimated protection against the omicron variants.
https://acpinternist.org/weekly/archives/2023/01/24/2.htm
24 Jan 2023